Intestinal Research
Scope & Guideline
Connecting Researchers to Transform Intestinal Health
Introduction
Aims and Scopes
- Investigation of Inflammatory Bowel Diseases (IBD):
The journal consistently publishes research on the clinical characteristics, treatment approaches, and long-term outcomes of IBD, particularly Crohn's disease and ulcerative colitis. - Clinical Trials and Real-World Studies:
There is a strong emphasis on both randomized controlled trials and real-world observational studies that evaluate the efficacy and safety of various therapies for IBD, including biologics and small molecules. - Innovative Diagnostic Approaches:
The journal highlights studies utilizing advanced imaging techniques, biomarkers, and endoscopic methods to improve diagnosis and monitoring of gastrointestinal diseases. - Multidisciplinary Perspectives:
Research often incorporates insights from gastroenterology, immunology, nutrition, and surgery, reflecting a holistic approach to managing gastrointestinal disorders. - Focus on Asian Populations:
A significant portion of the research addresses the unique clinical characteristics and treatment responses in Asian populations, contributing valuable data to the global understanding of IBD.
Trending and Emerging
- Biomarkers and Precision Medicine:
An increasing number of studies focus on identifying biomarkers that predict treatment response and disease progression, suggesting a trend towards precision medicine in managing IBD. - Impact of Gut Microbiota:
Research exploring the role of gut microbiota in IBD pathogenesis, treatment response, and overall health is gaining momentum, indicating a growing interest in microbiome-targeted therapies. - Mental Health and Quality of Life:
There is a rising emphasis on the psychosocial aspects of living with IBD, including mental health issues and quality of life assessments, reflecting a holistic approach to patient care. - COVID-19 and IBD Patients:
Research examining the effects of COVID-19 on patients with IBD has emerged as a significant theme, particularly regarding vaccination impacts and disease management during the pandemic. - New Therapeutic Agents:
The exploration of novel therapeutic agents, including JAK inhibitors and other small molecules, is becoming increasingly prevalent, as researchers seek to expand treatment options for refractory cases.
Declining or Waning
- Traditional Medical Therapies:
There is a noticeable decline in studies focusing exclusively on traditional medical therapies like corticosteroids, as newer treatment options such as biologics and small molecules gain prominence. - Basic Science Research:
The journal has shifted its focus away from purely basic science studies, particularly those that do not directly translate into clinical practice or patient outcomes. - Epidemiological Studies:
While still present, there appears to be a decrease in the publication of broad epidemiological studies related to IBD, possibly due to an increased emphasis on targeted clinical trials and specific therapeutic interventions. - Single-Center Studies:
There is a diminishing trend in the publication of single-center studies, as the journal increasingly favors multicenter collaborations that offer broader data and more robust conclusions. - Case Reports:
The frequency of case reports has declined, likely due to a preference for studies that provide larger datasets and more generalizable findings.
Similar Journals
DIGESTIVE AND LIVER DISEASE
Unlocking the complexities of digestive and liver diseases.DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.
Frontline Gastroenterology
Advancing the Frontiers of GastroenterologyFrontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.
Gastroenterology Research
Fostering collaboration in the pursuit of gastrointestinal health.Gastroenterology Research is a prominent scholarly journal dedicated to advancing the field of gastroenterology. Published by ELMER PRESS INC, this journal serves as a vital platform for disseminating innovative research, clinical findings, and comprehensive reviews that explore the complexities of the gastrointestinal system. With an ISSN of 1918-2805 and an E-ISSN of 1918-2813, it reaches a global audience of researchers, healthcare professionals, and students eager to contribute to or keep abreast of the latest developments in gastroenterology. Though details such as the H-index and Scopus rankings are currently unspecified, the journal's commitment to quality and impact in the medical research community is evident. Gastroenterology Research aims to foster collaboration and knowledge sharing among experts, ultimately improving patient care and outcomes within this critical area of health science. Explore the cutting-edge studies published within its pages and engage with a community passionate about the investigation and treatment of gastrointestinal diseases.
DIGESTION
Championing scholarly contributions in gastroenterology since 1896.DIGESTION is a prestigious journal dedicated to advancing the field of gastroenterology, published by KARGER, a renowned publisher based in Switzerland. With a rich history dating back to 1896, this journal has continuously evolved and serves as a vital platform for researchers, professionals, and students alike. DIGESTION is recognized for its scholarly contributions, holding an impressive rank of 23 out of 167 in the Scopus database, placing it within the top 14% of gastroenterology journals, as evidenced by its Q2 classification. The journal's commitment to high-quality research is reflected in its wide-ranging scope, addressing various aspects of digestive health, clinical practices, and innovative therapies. Though not an open-access journal, it provides comprehensive access options that ensure the dissemination of crucial research findings to the global community. As we move towards 2024, DIGESTION continues to facilitate dialogue and insights in gastroenterological research, making it an indispensable resource for those in the field.
Saudi Journal of Gastroenterology
Championing open access to vital gastroenterological findings.The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.
Gastroenterology Insights
Transforming Insights into Impactful DiscoveriesGastroenterology Insights is a premier open-access journal published by MDPI since 2009, focusing on essential research and developments within the fields of gastroenterology and hepatology. With a dedicated ISSN of 2036-7414 and E-ISSN 2036-7422, this journal serves as a vital platform for disseminating innovative studies and insights pertinent to gastrointestinal health, disorders, and treatment modalities. Based in Switzerland, Gastroenterology Insights boasts a significant academic presence, currently positioned in the Q3 quartile for both gastroenterology and hepatology categories as of 2023, reflecting its impactful contributions to the disciplines. With Scopus rankings placing it at the 94th and 48th positions in gastroenterology and hepatology respectively, the journal is committed to advancing knowledge and fostering collaboration among researchers, professionals, and students alike. By providing an open-access model, it ensures that high-quality research is accessible globally, thereby enhancing the reach and impact of crucial findings in the science of digestive health. Researchers looking to publish cutting-edge work will find Gastroenterology Insights a valuable resource for both sharing and acquiring knowledge.
DISEASES OF THE COLON & RECTUM
Connecting Researchers and Clinicians in Colorectal CareDISEASES OF THE COLON & RECTUM, published by Lippincott Williams & Wilkins, stands as a critical resource in the field of gastroenterology, focusing on the comprehensive study and management of colorectal diseases. With an ISSN of 0012-3706 and an E-ISSN of 1530-0358, this journal serves a diverse audience, including researchers, clinicians, and students interested in the latest advancements in this vital area of medicine. Recognized for its quality, it holds a Q2 ranking in both Gastroenterology and Miscellaneous Medicine categories for 2023 and is positioned at the 58th percentile within its Scopus rank. Since its inception in 1958, the journal has dedicated itself to disseminating original research, reviews, and clinical studies, providing a platform for sharing innovative findings that drive the field forward. While it is not an open access journal, its content remains pivotal for professionals looking to stay apprised of evidence-based practices and emerging trends in colorectal health. With ongoing contributions expected until 2024, DISEASES OF THE COLON & RECTUM continues to be an indispensable source of knowledge for anyone engaged in the intricacies of digestive health.
Canadian Journal of Gastroenterology and Hepatology
Connecting Researchers and Practitioners in Digestive HealthCanadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.
United European Gastroenterology Journal
Advancing knowledge in gastroenterology and oncology.The United European Gastroenterology Journal, published by John Wiley & Sons Ltd, is a leading publication in the fields of gastroenterology and oncology, boasting a distinguished Q1 ranking in both categories for 2023. With an ISSN of 2050-6406 and an E-ISSN of 2050-6414, this journal serves as a vital platform for disseminating cutting-edge research and innovative practices from 2013 to 2024, supporting the advancement of knowledge in gastrointestinal health and cancer treatment. With a commendable Scopus Rank of 14th out of 167 in gastroenterology and 54th out of 404 in oncology, it emphasizes the significance of impactful research in these critical areas. While currently not an open-access journal, it remains a vital resource for researchers, professionals, and students seeking comprehensive insights and evidence-based approaches to improve patient care and clinical outcomes. The United European Gastroenterology Journal is committed to bridging the gap between research and practice, making it an essential reference for those dedicated to the fields of gastroenterology and oncology.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Exploring Innovations in Gastroenterology Since 1966SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, published by Taylor & Francis Ltd, is a leading journal in the field of gastroenterology, dedicated to advancing clinical and experimental research related to digestive health. With an ISSN of 0036-5521 and an E-ISSN of 1502-7708, this journal provides a platform for high-quality research that addresses the complexities of gastrointestinal diseases. Since its inception in 1966, the journal has consistently contributed valuable insights and is currently categorized in the Q2 quartile of gastroenterology journals, reflecting its impact and relevance in the field, with a Scopus rank of 87 out of 167 in Medicine - Gastroenterology. Researchers and practitioners are encouraged to explore the journal's archives to enhance their understanding and stay abreast of innovative strategies for managing gastrointestinal disorders. The SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY remains a crucial resource for those committed to improving patient outcomes through rigorous scientific inquiry and the sharing of impactful findings.